4N2 Lymphoma, B cell & sentinel (Case 4) neoplastic area Ki67 20X | Sentinel & Steroid Rx Lesions | MYELIN (IMMUNE-MEDIATED)

Washington University Experience | MYELIN (IMMUNE-MEDIATED) | Sentinel & Steroid Rx Lesions | 4N2 Lymphoma, B cell & sentinel (Case 4) neoplastic area Ki67 20X

Demonstration of high proliferative activity in lymphoma rich portions of the specimen (Ki67 IHC).